Advanced

Memantine and reduced time with dyskinesia in Parkinson's Disease.

Wictorin, Klas LU and Widner, Håkan LU (2015) In Acta Neurologica Scandinavica
Abstract
The partial glutamate antagonist amantadine is currently used in clinical practice, to reduce dyskinesia developing as a side-effect of levodopa treatment in patients suffering from Parkinson's disease (PD). This study was aimed at evaluating the antidyskinetic effect of another glutamate antagonist, memantine.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Acta Neurologica Scandinavica
publisher
Wiley-Blackwell
external identifiers
  • pmid:26234336
  • scopus:84939216978
  • wos:000373774300005
ISSN
1600-0404
DOI
10.1111/ane.12468
language
English
LU publication?
yes
id
c53b7c98-faff-4e7d-97fe-05c16a886a4b (old id 7845005)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26234336?dopt=Abstract
date added to LUP
2015-09-05 12:10:06
date last changed
2017-08-06 04:10:10
@article{c53b7c98-faff-4e7d-97fe-05c16a886a4b,
  abstract     = {The partial glutamate antagonist amantadine is currently used in clinical practice, to reduce dyskinesia developing as a side-effect of levodopa treatment in patients suffering from Parkinson's disease (PD). This study was aimed at evaluating the antidyskinetic effect of another glutamate antagonist, memantine.},
  author       = {Wictorin, Klas and Widner, Håkan},
  issn         = {1600-0404},
  language     = {eng},
  month        = {08},
  publisher    = {Wiley-Blackwell},
  series       = {Acta Neurologica Scandinavica},
  title        = {Memantine and reduced time with dyskinesia in Parkinson's Disease.},
  url          = {http://dx.doi.org/10.1111/ane.12468},
  year         = {2015},
}